Afya (NASDAQ:AFYA) Reaches New 52-Week Low - Time to Sell?

Key Points

• Afya Limited's stock hit a new 52-week low at $14.43, closing at $14.54 with a trading volume of 18,836 shares.
• Analyst ratings indicate a consensus rating of "Hold", with one analyst upgrading it to "Buy" and a target price of $17.60.
• The company has a market cap of $1.37 billion and a P/E ratio of 11.00, reflecting a relatively low valuation.
• Institutional investors own 88.02% of Afya's stock, indicating strong interest from larger investment funds.

Afya Limited (NASDAQ:AFYA - Get Free Report) shares hit a new 52-week low during trading on Friday . The stock traded as low as $14.43 and last traded at $14.54, with a volume of 18836 shares. The stock had previously closed at $14.63.

Analyst Upgrades and Downgrades

AFYA has been the topic of several analyst reports. UBS Group restated a "neutral" rating and set a $19.50 price target (up previously from $17.50) on shares of Afya in a research note on Thursday, June 12th. Wall Street Zen lowered shares of Afya from a "buy" rating to a "hold" rating in a research note on Saturday. Finally, Citigroup upgraded shares of Afya from a "sell" rating to a "neutral" rating and dropped their price target for the stock from $16.00 to $14.00 in a research note on Tuesday. Two equities research analysts have rated the stock with a sell rating and four have given a hold rating to the company's stock. Based on data from MarketBeat.com, the company currently has a consensus rating of "Hold" and an average price target of $17.40.

Afya Stock Up 2.5%

The business's 50 day moving average is $17.18 and its 200-day moving average is $17.37. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.42 and a current ratio of 1.42. The firm has a market capitalization of $1.33 billion, a price-to-earnings ratio of 10.74, a price-to-earnings-growth ratio of 0.51 and a beta of 0.58.

Institutional Trading of Afya

A number of hedge funds have recently bought and sold shares of the stock. Perpetual Ltd lifted its holdings in Afya by 1.8% during the 2nd quarter. Perpetual Ltd now owns 151,180 shares of the company's stock valued at $2,700,000 after purchasing an additional 2,730 shares during the last quarter. Goldman Sachs Group Inc. grew its position in shares of Afya by 167.3% during the 1st quarter. Goldman Sachs Group Inc. now owns 45,093 shares of the company's stock worth $809,000 after buying an additional 28,226 shares during the period. Doma Perpetual Capital Management LLC grew its position in shares of Afya by 4.4% during the 1st quarter. Doma Perpetual Capital Management LLC now owns 592,220 shares of the company's stock worth $10,619,000 after buying an additional 25,111 shares during the period. Wealthedge Investment Advisors LLC acquired a new stake in shares of Afya during the 1st quarter worth approximately $230,000. Finally, Nuveen LLC bought a new position in Afya during the 1st quarter worth approximately $226,000. 88.02% of the stock is owned by institutional investors.

Afya Company Profile

Afya Limited, through its subsidiaries, operates as a medical education group in Brazil. The company operates through three segments: Undergrad, Continuing Education, and Digital Services. It offers educational products and services, including medical schools, medical residency preparatory courses, graduate courses, and other programs to lifelong medical learners enrolled across its distribution network, as well as to third-party medical schools.